Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / SNDX - Syndax Pharmaceuticals EPS beats by $0.13 beats on revenue


SNDX - Syndax Pharmaceuticals EPS beats by $0.13 beats on revenue

Syndax Pharmaceuticals (SNDX): Q1 GAAP EPS of -$0.54 beats by $0.13.Revenue of $0.38M (flat Y/Y) beats by $0.15M.For the second quarter of 2021, research and development expenses are expected to be $30 to $35 million, and total operating expenses are expected to be $35 to $40 million. For the full year of 2021, research and development expenses are expected to be $90 to $100 million, and total operating expenses are expected to be $110 to $120 million.Press Release

For further details see:

Syndax Pharmaceuticals EPS beats by $0.13, beats on revenue
Stock Information

Company Name: Syndax Pharmaceuticals Inc.
Stock Symbol: SNDX
Market: NASDAQ
Website: syndax.com

Menu

SNDX SNDX Quote SNDX Short SNDX News SNDX Articles SNDX Message Board
Get SNDX Alerts

News, Short Squeeze, Breakout and More Instantly...